Bone cancer
HealthExperimental cancer drug eliminates breast cancer bone metastasis
Johns Hopkins researchers find that RK-33, a drug targeting DDX3 protein, shows promise in treating breast cancer bone metastasis.
Rebecca Shavit
Johns Hopkins researchers find that RK-33, a drug targeting DDX3 protein, shows promise in treating breast cancer bone metastasis.
Rebecca Shavit